Novel Immune Targets in Melanoma-Response

Jarem Edwards; Marcel Batten; Angela Ferguson; Umaimainthan Palendira; James S Wilmott; Georgina V Long; Richard A Scolyer

doi:10.1158/1078-0432.CCR-19-1866

Novel Immune Targets in Melanoma-Response

Clin Cancer Res. 2019 Sep 1;25(17):5424-5425. doi: 10.1158/1078-0432.CCR-19-1866.

Authors

Jarem Edwards^{1

2

3

4}, Marcel Batten^{1

4}, Angela Ferguson^{2

3

4}, Umaimainthan Palendira^#^{2

3

4}, James S Wilmott^#^{1

2

4}, Georgina V Long^#^{1

2

4

5

6}, Richard A Scolyer^#^{7

2

4

8}

Affiliations

¹ Melanoma Institute Australia, The University of Sydney, North Sydney, New South Wales, Australia.
² Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
³ Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia.
⁴ Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
⁵ Mater Hospital, North Sydney, Australia.
⁶ Royal North Shore Hospital, Sydney, New South Wales, Australia.
⁷ Melanoma Institute Australia, The University of Sydney, North Sydney, New South Wales, Australia. Richard.Scolyer@melanoma.org.au.
⁸ Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

^# Contributed equally.

PMID: 31481485
DOI: 10.1158/1078-0432.CCR-19-1866

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Immunotherapy
Melanoma*
Prevalence